Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Impedimed Limited ( (AU:IPD) ) has issued an announcement.
ImpediMed Limited has released its Annual Report for the financial year ending 30 June 2025. This announcement marks a significant step in the company’s ongoing efforts to enhance transparency and communication with its stakeholders, potentially impacting its market positioning and stakeholder relations positively.
The most recent analyst rating on (AU:IPD) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Impedimed Limited stock, see the AU:IPD Stock Forecast page.
More about Impedimed Limited
ImpediMed Limited operates in the healthcare industry, focusing on transforming patient-centered care. The company is known for its innovative products and services aimed at improving patient outcomes.
Average Trading Volume: 2,554,679
Technical Sentiment Signal: Sell
Current Market Cap: A$89.31M
For a thorough assessment of IPD stock, go to TipRanks’ Stock Analysis page.